Payment overview · 2025
General Payments
$45.98
2 reported records · 1 companies
Healthcare provider profile · identity verified
Osahon John Obakpolor, MD
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · PITTSBURGH, PA · NPI 1477849628
Verified facts
What the public records show
CMS Open Payments records show Osahon John Obakpolor, MD received $45.98 in general payments during 2025 across 2 reported records.
ACADIA Pharmaceuticals Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $45.98 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $45.98 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $45.98 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 687 | 83 |
| Atorvastatin Calcium | Atorvastatin Calcium | 673 | 125 |
| Amlodipine Besylate | Amlodipine Besylate | 452 | 85 |
| Furosemide | Furosemide | 383 | 70 |
| Mirtazapine | Mirtazapine | 325 | 54 |
| Eliquis | Apixaban | 320 | 52 |
| Sertraline Hcl | Sertraline Hcl | 297 | 48 |
| Potassium Chloride | Potassium Chloride | 296 | 72 |
| Gabapentin | Gabapentin | 255 | 48 |
| Lisinopril | Lisinopril | 248 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 234 | 28 |
| Famotidine | Famotidine | 203 | 38 |
| Carvedilol | Carvedilol | 183 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 182 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 180 | 37 |
| Donepezil Hcl | Donepezil Hcl | 178 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 176 | 22 |
| Pantoprazole Sodium | Pantoprazole Sodium | 163 | 42 |
| Omeprazole | Omeprazole | 158 | 37 |
| Memantine Hcl | Memantine Hcl | 155 | 26 |
| Buspirone Hcl | Buspirone Hcl | 153 | 23 |
| Trazodone Hcl | Trazodone Hcl | 153 | 34 |
| Tamsulosin Hcl | Tamsulosin Hcl | 149 | 34 |
| Clopidogrel | Clopidogrel Bisulfate | 135 | 26 |
| Losartan Potassium | Losartan Potassium | 131 | 32 |
| Fluoxetine Hcl | Fluoxetine Hcl | 124 | 15 |
| Metformin Hcl | Metformin Hcl | 120 | 27 |
| Bumetanide | Bumetanide | 112 | 21 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 111 | 25 |
| Metformin Hcl Er | Metformin Hcl | 106 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 105 | 13 |
| Finasteride | Finasteride | 104 | 15 |
| Cephalexin | Cephalexin | 102 | 57 |
| Myrbetriq | Mirabegron | 102 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 98 | 20 |
| Montelukast Sodium | Montelukast Sodium | 93 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 91 | suppressed |
| Allopurinol | Allopurinol | 87 | suppressed |
| Levetiracetam | Levetiracetam | 83 | 19 |
| Divalproex Sodium | Divalproex Sodium | 79 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 79 | 13 |
| Klor-Con M20 | Potassium Chloride | 75 | 11 |
| Simvastatin | Simvastatin | 74 | 16 |
| Meloxicam | Meloxicam | 72 | 21 |
| Nifedipine Er | Nifedipine | 70 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 27 |
| Alendronate Sodium | Alendronate Sodium | 68 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 67 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 65 | 14 |
| Januvia | Sitagliptin Phosphate | 64 | suppressed |
| Baclofen | Baclofen | 61 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 61 | 27 |
| Jardiance | Empagliflozin | 61 | suppressed |
| Aripiprazole | Aripiprazole | 58 | suppressed |
| Atenolol | Atenolol | 58 | 12 |
| Valsartan | Valsartan | 58 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 56 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 55 | suppressed |
| Latanoprost | Latanoprost | 54 | 14 |
| Midodrine Hcl | Midodrine Hcl | 54 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 54 | suppressed |
| Multaq | Dronedarone Hcl | 52 | suppressed |
| Trulicity | Dulaglutide | 52 | suppressed |
| Clonazepam | Clonazepam | 49 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 48 | 16 |
| Pregabalin | Pregabalin | 47 | 12 |
| Spironolactone | Spironolactone | 47 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 42 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 41 | 33 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 28 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 39 | suppressed |
| Lactulose | Lactulose | 38 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 38 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 38 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Digoxin | Digoxin | 36 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 36 | suppressed |
| Torsemide | Torsemide | 36 | suppressed |
| Bupropion Xl | Bupropion Hcl | 35 | suppressed |
| Risperidone | Risperidone | 35 | suppressed |
| Xarelto | Rivaroxaban | 34 | suppressed |
| Azithromycin | Azithromycin | 33 | 27 |
| Ceftriaxone | Ceftriaxone Sodium | 33 | 24 |
| Colestipol Hcl | Colestipol Hcl | 33 | suppressed |
| Metolazone | Metolazone | 33 | suppressed |
| Celecoxib | Celecoxib | 32 | suppressed |
| Cefdinir | Cefdinir | 31 | 22 |
| Ezetimibe | Ezetimibe | 31 | suppressed |
| Lorazepam | Lorazepam | 29 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 29 | 16 |
| Ranolazine Er | Ranolazine | 29 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 28 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 23 |
| Scopolamine | Scopolamine | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 20 |
| Morphine Sulfate Er | Morphine Sulfate | 27 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | 24 |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 27 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Prednisone | Prednisone | 25 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 24 | suppressed |
| Budesonide | Budesonide | 24 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 24 | 14 |
| Topiramate | Topiramate | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Trospium Chloride | Trospium Chloride | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | 11 |
| Tolterodine Tartrate | Tolterodine Tartrate | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Levofloxacin | Levofloxacin | 20 | 14 |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Nystatin | Nystatin | 19 | 16 |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | 18 |
| Xifaxan | Rifaximin | 19 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | suppressed |
| Gemtesa | Vibegron | 18 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 18 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Rytary | Carbidopa/Levodopa | 18 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Mirabegron Er | Mirabegron | 17 | suppressed |
| Phenytek | Phenytoin Sodium Extended | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 12 |
| Tradjenta | Linagliptin | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 16 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 16 | 14 |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Acetic Acid | Acetic Acid | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 15 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 14 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Fenofibrate | Fenofibrate | 14 | suppressed |
| Hydroxyurea | Hydroxyurea | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | 11 |
| Olanzapine | Olanzapine | 13 | suppressed |
| Perphenazine | Perphenazine | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Rivastigmine | Rivastigmine | 13 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Sucralfate | Sucralfate | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Clobazam | Clobazam | 11 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 11 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $45.98 · 2 records | ACADIA Pharmaceuticals Inc | NUPLAZID | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error